Cargando…
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
BACKGROUND: While large-scale cancer genomic projects are comprehensively characterizing the mutational spectrum of various cancers, so far little attention has been devoted to either define the antigenicity of these mutations or to characterize the immune responses they elicit. Here we present a st...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377852/ https://www.ncbi.nlm.nih.gov/pubmed/25853550 http://dx.doi.org/10.1186/s13059-015-0620-6 |
_version_ | 1782363971260514304 |
---|---|
author | Angelova, Mihaela Charoentong, Pornpimol Hackl, Hubert Fischer, Maria L Snajder, Rene Krogsdam, Anne M Waldner, Maximilian J Bindea, Gabriela Mlecnik, Bernhard Galon, Jerome Trajanoski, Zlatko |
author_facet | Angelova, Mihaela Charoentong, Pornpimol Hackl, Hubert Fischer, Maria L Snajder, Rene Krogsdam, Anne M Waldner, Maximilian J Bindea, Gabriela Mlecnik, Bernhard Galon, Jerome Trajanoski, Zlatko |
author_sort | Angelova, Mihaela |
collection | PubMed |
description | BACKGROUND: While large-scale cancer genomic projects are comprehensively characterizing the mutational spectrum of various cancers, so far little attention has been devoted to either define the antigenicity of these mutations or to characterize the immune responses they elicit. Here we present a strategy to characterize the immunophenotypes and the antigen-ome of human colorectal cancer. RESULTS: We apply our strategy to a large colorectal cancer cohort (n = 598) and show that subpopulations of tumor-infiltrating lymphocytes are associated with distinct molecular phenotypes. The characterization of the antigenome shows that a large number of cancer-germline antigens are expressed in all patients. In contrast, neo-antigens are rarely shared between patients, indicating that cancer vaccination requires individualized strategy. Analysis of the genetic basis of the tumors reveals distinct tumor escape mechanisms for the patient subgroups. Hypermutated tumors are depleted of immunosuppressive cells and show upregulation of immunoinhibitory molecules. Non-hypermutated tumors are enriched with immunosuppressive cells, and the expression of immunoinhibitors and MHC molecules is downregulated. Reconstruction of the interaction network of tumor-infiltrating lymphocytes and immunomodulatory molecules followed by a validation with 11 independent cohorts (n = 1,945) identifies BCMA as a novel druggable target. Finally, linear regression modeling identifies major determinants of tumor immunogenicity, which include well-characterized modulators as well as a novel candidate, CCR8, which is then tested in an orthologous immunodeficient mouse model. CONCLUSIONS: The immunophenotypes of the tumors and the cancer antigenome remain widely unexplored, and our findings represent a step toward the development of personalized cancer immunotherapies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0620-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4377852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43778522015-03-31 Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy Angelova, Mihaela Charoentong, Pornpimol Hackl, Hubert Fischer, Maria L Snajder, Rene Krogsdam, Anne M Waldner, Maximilian J Bindea, Gabriela Mlecnik, Bernhard Galon, Jerome Trajanoski, Zlatko Genome Biol Research BACKGROUND: While large-scale cancer genomic projects are comprehensively characterizing the mutational spectrum of various cancers, so far little attention has been devoted to either define the antigenicity of these mutations or to characterize the immune responses they elicit. Here we present a strategy to characterize the immunophenotypes and the antigen-ome of human colorectal cancer. RESULTS: We apply our strategy to a large colorectal cancer cohort (n = 598) and show that subpopulations of tumor-infiltrating lymphocytes are associated with distinct molecular phenotypes. The characterization of the antigenome shows that a large number of cancer-germline antigens are expressed in all patients. In contrast, neo-antigens are rarely shared between patients, indicating that cancer vaccination requires individualized strategy. Analysis of the genetic basis of the tumors reveals distinct tumor escape mechanisms for the patient subgroups. Hypermutated tumors are depleted of immunosuppressive cells and show upregulation of immunoinhibitory molecules. Non-hypermutated tumors are enriched with immunosuppressive cells, and the expression of immunoinhibitors and MHC molecules is downregulated. Reconstruction of the interaction network of tumor-infiltrating lymphocytes and immunomodulatory molecules followed by a validation with 11 independent cohorts (n = 1,945) identifies BCMA as a novel druggable target. Finally, linear regression modeling identifies major determinants of tumor immunogenicity, which include well-characterized modulators as well as a novel candidate, CCR8, which is then tested in an orthologous immunodeficient mouse model. CONCLUSIONS: The immunophenotypes of the tumors and the cancer antigenome remain widely unexplored, and our findings represent a step toward the development of personalized cancer immunotherapies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0620-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-31 2015 /pmc/articles/PMC4377852/ /pubmed/25853550 http://dx.doi.org/10.1186/s13059-015-0620-6 Text en © Angelova et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Angelova, Mihaela Charoentong, Pornpimol Hackl, Hubert Fischer, Maria L Snajder, Rene Krogsdam, Anne M Waldner, Maximilian J Bindea, Gabriela Mlecnik, Bernhard Galon, Jerome Trajanoski, Zlatko Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy |
title | Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy |
title_full | Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy |
title_fullStr | Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy |
title_full_unstemmed | Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy |
title_short | Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy |
title_sort | characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377852/ https://www.ncbi.nlm.nih.gov/pubmed/25853550 http://dx.doi.org/10.1186/s13059-015-0620-6 |
work_keys_str_mv | AT angelovamihaela characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT charoentongpornpimol characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT hacklhubert characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT fischermarial characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT snajderrene characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT krogsdamannem characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT waldnermaximilianj characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT bindeagabriela characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT mlecnikbernhard characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT galonjerome characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy AT trajanoskizlatko characterizationoftheimmunophenotypesandantigenomesofcolorectalcancersrevealsdistincttumorescapemechanismsandnoveltargetsforimmunotherapy |